BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6958076)

  • 21. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cultivation of bone marrow and blood cells of patients with acute leukemia in agar medium].
    Frenkel' MA; Kharlamova LA; Shereshkov SI; Volkova MA
    Ter Arkh; 1983; 55(8):133-6. PubMed ID: 6579692
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hematopoietic cell cultures in hematology].
    Kolesnikova AI
    Ter Arkh; 1983; 55(8):122-30. PubMed ID: 6579691
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow microenvironment of patients with systemic lupus erythematosus.
    Otsuka T; Nagasawa K; Harada M; Niho Y
    J Rheumatol; 1993 Jun; 20(6):967-71. PubMed ID: 8350332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.
    Bendall LJ; Daniel A; Kortlepel K; Gottlieb DJ
    Exp Hematol; 1994 Dec; 22(13):1252-60. PubMed ID: 7957711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia.
    Pejsa V; Kusec R; Petrovecki M; Jaksic O; Jaksic B; Boranic M
    Haematologica; 2003 Dec; 88(12):1429-31. PubMed ID: 14688001
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytogenetical studies on erythropoietic and myelopoietic progenitor cells in vitro in chronic myelogenous leukemia (author's transl)].
    Grilli G; Carbonell F; Fliedner TM
    Haematologica; 1981 Dec; 66(6):733-9. PubMed ID: 6802714
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
    Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
    Bone Marrow Transplant; 2004 Apr; 33(7):721-8. PubMed ID: 14743200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytodynamics of bone marrow precursors at different developmental stages of chronic granulocytic leukemia].
    Outeiriño J; Fernández Rañada JM; Sánchez Fayos J
    Sangre (Barc); 1984; 29(4-B):565-76. PubMed ID: 6595818
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stromal cells, the precursors of bone marrow, in chronic myeloleukemia patients].
    Domracheva EV; Kolesnikova AI; Vorob'ev AI; Brilliant MD; Khoptynskaia SK
    Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):16-9. PubMed ID: 6931365
    [No Abstract]   [Full Text] [Related]  

  • 33. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
    Chávez-González A; Ayala-Sánchez M; Sánchez-Valle E; Ruiz-Sánchez E; Arana-Trejo RM; Vela-Ojeda J; Mayani H
    Leuk Res; 2006 Mar; 30(3):286-95. PubMed ID: 16111748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clonal proliferation of the hematopoietic stem cells from patients with myelocytic leukemia in in vivo culture].
    Hansz J; Pytlak B; Drozdowska D
    Pol Arch Med Wewn; 1980 Aug; 64(2):125-32. PubMed ID: 6933422
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased numbers of bone marrow blasts in acute myeloid leukaemia patients treated with G-CSF after chemotherapy.
    Kaddar A; Edinger M; Wirth K; Schaefer HE; Lübbert M; Lindemann A
    Br J Haematol; 1997 Aug; 98(2):492-3. PubMed ID: 9266958
    [No Abstract]   [Full Text] [Related]  

  • 37. [Changes in S-phase CFU-c in chronic myelocytic leukemia].
    Umeda M; Shirai T
    Rinsho Ketsueki; 1983 Feb; 24(2):126-32. PubMed ID: 6581345
    [No Abstract]   [Full Text] [Related]  

  • 38. Human bone marrow granulocyte-macrophageal colonies (GM-Cs) in vitro: myeloid cells in health and in cases of myeloid leukemia.
    Zvetkova E; Savov Y; Gluhcheva Y; Ilieva I; Bichkidjieva E; Katzarova E; Tsenov I
    Clin Hemorheol Microcirc; 2004; 30(3-4):481-4. PubMed ID: 15258392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation.
    Ferguson SM
    Ala J Med Sci; 1981 Jul; 18(3):239-42. PubMed ID: 7025681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.